Shares of Guided Therapeutics (GTHP.OB) fall 52.5% premarket on reports that the firm's cash...

|About: Guided Therapeutics, Inc. (GTHP-OLD)|By:, SA News Editor

Shares of Guided Therapeutics (GTHP.OB) fall 52.5% premarket on reports that the firm's cash position is dangerously low and that the application for approval with the EU for its Luliva treatment (.pdf) is only a head fake for potential trouble it's having landing approval with the FDA in the U.S.